3 hours Is Amgen Stock Still a Buy After an Unexpected Reveal of Data?The Motley Fool
Shares of Amgen (NASDAQ: AMGN) are down by 6% in the last 30 days as I write this — a larger-than-normal amount for a large pharma company’s stock to fall, especially considering that the market rose nearly 3% in the same period. The clear culprit for…
X